stars 1 stars 2 stars 3

At TTS Pharma, we are committed to advancing the medicinal cannabis and wellness industries through innovation, integrity, and scientific excellence. With a strong foundation in research, regulatory compliance, and product development, we deliver high-quality cannabinoid-based solutions that meet the evolving needs of healthcare professionals, patients, and consumers. Our expertise spans the entire supply chain, from cultivation and extraction to formulation and distribution, ensuring the highest standards of safety, efficacy, and consistency. We work closely with regulators, medical professionals, and industry leaders to drive progress in cannabinoid-based healthcare while adhering to the strictest compliance frameworks. With a team focused on quality, transparency, and sustainability, we are dedicated to shaping the future of medicinal cannabis and wellness solutions. Whether through our own product lines or strategic partnerships, we empower businesses and healthcare providers with trusted, high-purity cannabinoid products tailored to market demands. Join us on our mission to set new benchmarks in medicinal cannabis and wellness innovation.

TTS Pharma Questions

The TTS Pharma annual revenue was $192000 in 2026.

Mark Tucker is the CEO of TTS Pharma.

2 people are employed at TTS Pharma.

The NAICS codes for TTS Pharma are [32541, 325, 32, 3254].

The SIC codes for TTS Pharma are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users